Avita Medical share price climbs on new collaboration

The Avita Medical Ltd (ASX: AVH) share price has rocketed higher in early trade after a new collaboration with the University of Colorado.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Avita Medical Ltd (ASX: AVH) share price has shot 3.93% higher in early trade after announcing a new collaboration with the University of Colorado.

Why is the Avita Medical share price climbing higher?

This morning, Avita announced that it will collaborate with scientists at the Gates Center for Regenerative Medicine at the University of Colorado.

The preclinical research collaboration will work to establish proof of concept and explore further development of a spray-on treatment. The treatment is targeted at genetically modified cells for patients with epidermolysis bullosa (EB).

EB is a group of rare and incurable skin disorders caused by genetic mutation, which can result in skin fragility and blistering.

The Aussie medical company also hopes to find applicability for other genetic skin disorders.

The partnership will pair Avita Medical's patented and proprietary Spray-On Skin Cells expertise with the Gates Center's own technology. Avita will retain the option to exclusively license technologies emerging from the partnership.

Director of the Gates Center for Regenerative Medicine, Dr. Dennis Roop, was excited by the partnership.

Dr. Roop said the Spray-On Skin Cells technology combined with the Center's genetically corrected cells "has the potential to be game changing in the treatment of this disease".

At the time of writing, the Avita share price is up nearly 4% to $0.58 per share.

How has Avita performed in 2019?

It's been a busy 2019 for the Aussie medical group, with the Avita Medical share price rocketing higher across the year.

Avita recently joined the ASX 200 after surging an astonishing 625% higher in 2019. The company currently boasts a market cap of $1.2 billion following its strong share market performance this year.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A hipster dude leaps in the air with glee, seeing positive news on his tablet.
Healthcare Shares

Which ASX 200 stock is jumping 11% on big news?

Investors are responding very positively to a big announcement.

Read more »

Senior woman using cpap machine to stop choking and snoring from obstructive sleep apnoea with bokeh and morning light background.
Healthcare Shares

Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell?

ResMed shares have surged more than 75% since October 2023, but is it too late to buy? We break down…

Read more »

Stethoscope with a piggy bank in the middle.
Broker Notes

Australian health insurance: Does Macquarie prefer Medibank or NIB shares?

Medibank and NIB shares have both surged in 2025. Here’s what Macquarie expects now.

Read more »

Two brokers analysing stocks.
Healthcare Shares

Why does Macquarie think Fisher & Paykel shares are a buy?

Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH) shares have been on form over the past 12 months. During this…

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Healthcare Shares

Which small cap ASX share is jumping 10% on strong results

Investors have been bidding this stock higher today. But why?

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

Why Macquarie forecasts 30-50% upside for these ASX All Ords healthcare stocks

Macquarie updated its target price on these three ASX All Ords healthcare stocks.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX 200 stock is jumping 10% on big news

This stock is catching the eye with a strong gain on Thursday. But why?

Read more »

a young woman holds her hand to her ear and leans sideways as if to listen to something that's surprising her as her eyes and her mouth are wide open.
Healthcare Shares

Down 15% since January, are Cochlear shares now a buy?

Let's see what analysts are saying about this blue chip.

Read more »